Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 1, 2006, Pages 124-131

  Siepe, Matthias ^a,b   Giraud, Marie Noëlle ^b   Pavlovic, Mladen ^b   Receputo, Concetina ^a,b,c   Beyersdorf, Friedhelm ^a   Menasché, Philippe ^c   Carrel, Thierry ^b   Tevaearai, Hendrik T ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

POLYURETHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABLE IMPLANT; CELL DIFFERENTIATION; CELL MIGRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HISTOLOGY; IMMUNOHISTOLOGY; MALE; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; BIODEGRADATION, ENVIRONMENTAL; HEART RATE; HEMODYNAMIC PROCESSES; IMMUNOHISTOCHEMISTRY; MYOBLASTS, CARDIAC; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; RATS; RATS, INBRED LEW; STROKE VOLUME; TISSUE ENGINEERING; VENTRICULAR FUNCTION;

EID: 33745188299     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.01.052     Document Type: Article

References (24)

1. Murry C.E., Wiseman R.W., Schwartz S.M., and Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98 (1996) 2512-2523
2. Pouzet B., Ghostine S., Vilquin J.T., Garcin I., Scorsin M., Hagege A.A., et al. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?. Circulation 104 suppl I (2001) I223-I228
3. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., et al. Regenerating functional myocardium. improved performance after skeletal myoblast transplantation. Nat Med 4 (1998) 929-933
4. Smits P.C., van Geuns R.J., Poldermans D., Bountioukos M., Onderwater E.E., Lee C.H., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. clinical experience with six-month follow-up. J Am Coll Cardiol 42 (2003) 2063-2069
5. Siminiak T., Kalawski R., Fiszer D., Jerzykowska O., Rzezniczak J., Rozwadowska N., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury. phase I clinical study with 12 months of follow-up. Am Heart J 148 (2004) 531-537
6. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
7. Fan Y., Maley M., Beilharz M., and Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19 (1996) 853-860
8. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., and Murry C.E. Cardiomyocyte grafting for cardiac repair. graft cell death and anti-death strategies. J Mol Cell Cardiol 33 (2001) 907-921
9. Suzuki K., Murtuza B., Beauchamp J.R., Smolenski R.T., Varela-Carver A., Fukushima S., et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. Faseb J 18 (2004) 1153-1155
10. Siepe M., Giraud M., Tevaearai H., Nydegger U., Menasché P., and Carrel T. Biodegradable polyurethane scaffold seeded with myoblasts for myocardial repair. ASAIO J 50 abstr. (2004) 160
11. Leobon B., Garcin I., Menasche P., Vilquin J.T., Audinat E., and Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 100 (2003) 7808-7811
12. Pouzet B., Vilquin J.T., Hagege A.A., Scorsin M., Messas E., Fiszman M., et al. Intramyocardial transplantation of autologous myoblasts. can tissue processing be optimized?. Circulation 102 suppl 3 (2000) III210-III215
13. Gisselfalt K., Edberg B., and Flodin P. Synthesis and properties of degradable poly(urethane urea)s to be used for ligament reconstructions. Biomacromolecules 3 (2002) 951-958
14. Siepe M., Rüegg M., Giraud M., Python J., Carrel T., and Tevaearai H. Effect of acute body positional changes on the hemodynamics of rats with and without myocardial infarction. Exp Physiol 90 (2005) 627-634
15. Maurel A., Azarnoush K., Sabbah L., Vignier N., Le Lorc'h M., Mandet C., et al. Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium?. Transplantation 80 (2005) 660-665
16. Kellar R.S., Landeen L.K., Shepherd B.R., Naughton G.K., Ratcliffe A., and Williams S.K. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation 104 (2001) 2063-2068
17. Fukuhara S., Tomita S., Nakatani T., Fujisato T., Ohtsu Y., Ishida M., et al. Bone marrow cell-seeded biodegradable polymeric scaffold enhances angiogenesis and improves function of the infarcted heart. Circ J 69 (2005) 850-857
18. Barandon L., Couffinhal T., Dufourcq P., Alzieu P., Daret D., Deville C., et al. Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model. Ann Thorac Surg 78 (2004) 1409-1417
19. Pouzet B., Vilquin J.T., Hagege A.A., Scorsin M., Messas E., Fiszman M., et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 71 (2001) 844-850 discussion 50-1
20. Murtuza B., Suzuki K., Bou-Gharios G., Beauchamp J.R., Smolenski R.T., Partridge T.A., et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A 101 (2004) 4216-4221
21. Suzuki K., Murtuza B., Beauchamp J.R., Brand N.J., Barton P.J., Varela-Carver A., et al. Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation 110 suppl 1 (2004) II219-II224
22. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
23. Azarnoush K., Maurel A., Sebbah L., Carrion C., Bissery A., Mandet C., et al. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1α. J Thorac Cardiovasc Surg 130 (2005) 173-179
24. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 697-703